Replies to post #47858 on Ocata Therapeutics Inc fka OCAT

[farviewhill]

I couldn't agree more with the excellent points of observation and criticism you make.
Rabin's gotten a 'get out of jail card' and a ton of dollars to boot, after being involved in the toxic financing that has killed us financially/share-wise and seriously delayed our progress for quite a few years. And he touts his financial and hedge fund prowess! And to boot, he's manuevered himself into the ceo and cfo position, all the garbage language about looking for a ceo and now a cfo aside thrown at us over the years.
The Board, imo, has been and continues to be remiss in their responsibilities and certainly in being upfront with shareholders, their supposedly explanatory/full disclosure moments aside. But, frankly, as rabin said, we really don't care about you small time retail investors, to which I would respond that we've certainly been an important factor in keeping the company 'alive' all these years.

I have posted these thoughts for a few years now, even though I remain excited about the potential of the company.
That excitement diminishes with each passing year, since my entry in 2005. I will greatly surprise me if a cfo emerges anytime soon.
Further, the very troubling thing, is we're far from the only biotech out there that will be addressing amd and smd, plus other stem cell conditions,that will have the management and scientific team to more expertly move their company to being commercial, leaving actc as a promising has been.

[louisa]

You're hilarious. If Rabin is as you state, I find it amazing that we have a BOD who agreed to come on and major hospitals willing to participate in clinical trials. I have no clue what Gary does daily and if he deserves this salary and if he was part of the SEC suit but there is little we as retail investors can do to change any of this for now.

Bitching and moaning changes nothing. Whine a bit if it makes you feel better but in reality your choice is to stay with this or move on.

IMHO I think most of us are of the opinion that we will get some good news soon, and maybe that will be a good exit point for you. GL.

[runcaly]

"In fairness to Gary Rabin, Dr. Schwartz spoke of him in glowing terms and I would imagine he has dealt with a number of CEO and executive level officers in a good many of the trials he has done at JSEI. I can think of no reason that he would be so complimentary if it was not deserved."

from the ICELL-Board